Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

June 29, 2025

Study Completion Date

June 29, 2025

Conditions

Systemic Sclerosis

Interventions

OTHER

disease phenotype

evaluation of SSc phenotypes

Trial Locations (14)

CHU Angers, Angers

CHU Brest, Brest

CH Dunkerque, Dunkirk

CHU Grenoble, Grenoble

CHU Lille, Lille

Hospices Civils de Lyon, Lyon

AP-HM, Marseille

CHU Nice, Nice

APHP, Paris

CHU Poitiers, Poitiers

CHU Reims, Reims

CHU Rennes, Rennes

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT06412614 - Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies | Biotech Hunter | Biotech Hunter